Walden Biosciences
Signal active
Organization
Contact Information
Overview
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease. Founded by world-renowned experts in renal disease, Walden is applying its unique, systems-based approach to address the intersection between the pathology and biology of kidney disease.
About
Industries
Biotechnology, Life Science, Health Care
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Walden Biosciences headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care sector. The company focuses on Biotechnology and has secured $1.2B in funding across 24 round(s). With a team of 11-50 employees, Walden Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Walden Biosciences, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$51.0M
Details
2
Walden Biosciences has raised a total of $51.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 51.0M | ||
| 2023 | Early Stage Venture |
Investors
Walden Biosciences is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Walden Biosciences | - | FUNDING ROUND - Walden Biosciences | 51.0M |
| Mass General Brigham Ventures | - | FUNDING ROUND - Mass General Brigham Ventures | 51.0M |
| Walden Biosciences | - | FUNDING ROUND - Walden Biosciences | undefined |
| ATEM Capital Fund LP | - | FUNDING ROUND - ATEM Capital Fund LP | undefined |
Recent Activity
There is no recent news or activity for this profile.